6,264
Views
27
CrossRef citations to date
0
Altmetric
Therapeutics

Two-year integrated steroid-sparing analysis and safety of benralizumab for severe asthma

, MD, PhD, , MD, , MD, PhD, , MD, , MD, , MD, , MD, , MSc, , PhD, , MD & , MD show all
Pages 514-522 | Received 07 Nov 2019, Accepted 11 Dec 2019, Published online: 26 Dec 2019

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.